Literature DB >> 10836996

Reduced levels of connexin43 in cervical dysplasia: inducible expression in a cervical carcinoma cell line decreases neoplastic potential with implications for tumor progression.

T J King1, L H Fukushima, A D Hieber, K A Shimabukuro, W A Sakr, J S Bertram.   

Abstract

Loss of gap junctional intercellular communication (GJIC) has been linked to aberrant proliferation and an enhanced neoplastic phenotype. Many human tumors, including the cervical carcinoma line HeLa, have been reported to be deficient in expression of the gap junction protein connexin43 (Cx43) and GJIC. To determine if this is an early event in carcinogenesis, we utilized immunohistochemistry to screen a series of cervical biopsy samples and demonstrated a major reduction in Cx43 expression in dysplastic regions compared to normal epithelia. To determine whether this loss influences the neoplastic behavior of cervical carcinoma cells, we have constructed HeLa cell lines in which Cx43 expression can be induced in response to doxycycline. This approach allows for the discrimination of Cx43-mediated effects from those due to pre-existing clonal heterogeneity. Cx43 induction in these cells led to assembly of functional junctions but did not alter growth control in vitro as measured by logarithmic growth, saturation density or focus formation when in co-culture with growth-controlled fibroblasts. However, Cx43 induction decreased two indices of neoplasia: it reduced anchorage-independent growth and attenuated the growth rate of tumor xenografts. These results indicate that established HeLa cell lines are unresponsive to Cx43-mediated signals which are thought to mediate growth control of non-transformed cells, however, Cx43 expression can still reduce aspects of the neoplastic phenotype of these cells, indicating that loss of connexin signaling in dysplastic cells may contribute to their neoplastic progression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10836996

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  17 in total

1.  Tetracycline-regulated expression enables purification and functional analysis of recombinant connexin channels from mammalian cells.

Authors:  Irina V Koreen; Wafaa A Elsayed; Yu J Liu; Andrew L Harris
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

2.  Changes in connexin43 expression and localization during pancreatic cancer progression.

Authors:  Joell L Solan; Sunil R Hingorani; Paul D Lampe
Journal:  J Membr Biol       Date:  2012-06-23       Impact factor: 1.843

Review 3.  Putting tumours in context.

Authors:  M J Bissell; D Radisky
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

4.  Mucosal human papillomaviruses encode four different E5 proteins whose chemistry and phylogeny correlate with malignant or benign growth.

Authors:  Ignacio G Bravo; Angel Alonso
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 5.  The role of altered cell-cell communication in melanoma progression.

Authors:  Nikolas K Haass; Keiran S M Smalley; Meenhard Herlyn
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

6.  Altered tumor biology and tumorigenesis in irradiated and chemical carcinogen-treated single and combined connexin32/p27Kip1-deficient mice.

Authors:  Timothy J King; Paul D Lampe
Journal:  Cell Commun Adhes       Date:  2005 Jul-Dec

7.  Inhibition of gap junctional Intercellular communication in WB-F344 rat liver epithelial cells by triphenyltin chloride through MAPK and PI3-kinase pathways.

Authors:  Chung-Hsun Lee; I-Hui Chen; Chia-Rong Lee; Chih-Hsien Chi; Ming-Che Tsai; Jin-Lian Tsai; Hsiu-Fen Lin
Journal:  J Occup Med Toxicol       Date:  2010-06-30       Impact factor: 2.646

8.  Src-Induced cisplatin resistance mediated by cell-to-cell communication.

Authors:  Elizabeth Peterson-Roth; Cathleen M Brdlik; Peter M Glazer
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

9.  XIII International Charles Heidelberger Symposium and 50 Years of Fluoropyrimidines in Cancer Therapy Held on september 6 to 8, 2007 at New York University Cancer Institute, Smilow Conference Center.

Authors:  Franco M Muggia; Godefridus J Peters; Joseph R Landolph
Journal:  Mol Cancer Ther       Date:  2009-05-05       Impact factor: 6.261

10.  Inverse Relationship between Tumor Proliferation Markers and Connexin Expression in a Malignant Cardiac Tumor Originating from Mesenchymal Stem Cell Engineered Tissue in a Rat in vivo Model.

Authors:  Cathleen Spath; Franziska Schlegel; Sergey Leontyev; Friedrich-Wilhelm Mohr; Stefan Dhein
Journal:  Front Pharmacol       Date:  2013-04-17       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.